Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “interleukin-”

120 pharma patents match "interleukin-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 120
Index total 30,257
Page 5 / 5

Quick answer

This filtered view shows 120 pharmaceutical patents matching "interleukin-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

120 results for “interleukin-” · 30,257 patents in full index Clear search

  1. US 6576614

    Peptide analogs as irreversible interleukin-1&bgr; protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 10, 2003 · Expires Jun 5, 2023

    expired

  2. US 6573259

    Inhibitors of interleukin-1&bgr; converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2003 · Expires May 29, 2023

    expired

  3. US 6548055

    Immunologic enhancement with intermittent interleukin-2 therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 15, 2003 · Expires Apr 10, 2023

    expired

  4. US 6517839

    Methods for inducing interleukin-12 and a type1/Th1 T-cell response

    The Regents of the University of California · Granted Feb 11, 2003 · Expires Feb 6, 2023

    expired

  5. US 6423840

    Inhibitors of interleukin-1&bgr; converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Jul 23, 2002 · Expires Jul 18, 2022

    expired

  6. US 6420522

    Inhibitors of interleukin-1&bgr; converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Jul 16, 2002 · Expires Jul 11, 2022

    expired

  7. US 6407080

    N-(pyrimidinyl)-aspartic acid analogs as interleukin-1&bgr; converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 18, 2002 · Expires Jun 13, 2022

    expired

  8. US 6365768

    Interleukin-1 and tumor necrosis factors-&agr; modulators, syntheses of said modulators and methods of using modulators

    The Regents of the University of California · Granted Apr 2, 2002 · Expires Mar 28, 2022

    expired

  9. US 6350741

    Inhibitors of interleukin-1&bgr; converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 26, 2002 · Expires Feb 21, 2022

    expired

  10. US 6329365

    Inhibitors of interleukin-1.beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Dec 11, 2001 · Expires Dec 6, 2021

    expired

  11. US 6294169

    Interleukin-1 beta converting enzyme like apoptotic protease-6

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 25, 2001 · Expires Sep 20, 2021

    expired

  12. US 6258948

    Inhibitors of Interleukin-1.beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2001 · Expires Jul 5, 2021

    expired

  13. US 6251878

    Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotective tamarind oligosaccharides

    The Board of Regents of the University of Texas System · Granted Jun 26, 2001 · Expires Jun 21, 2021

    expired

  14. US 6239268

    Interleukin-1 type 3 receptors

    Neurocrine Biosciences, Inc. · Granted May 29, 2001 · Expires May 24, 2021

    expired

  15. US 6204261

    Inhibitors of interleukin-1.beta. Converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 20, 2001 · Expires Mar 15, 2021

    expired

  16. US 6190656

    Immunologic enhancement with intermittent interleukin-2 therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 20, 2001 · Expires Feb 15, 2021

    expired

  17. US 6191269

    Selective induction of cell death by delivery of amino-terminal interleukin-1-.alpha. pro-piece polypeptide

    The Regents of the University of California · Granted Feb 20, 2001 · Expires Feb 15, 2021

    expired

  18. US 6162800

    N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2000 · Expires Dec 14, 2020

    expired

  19. US 6162790

    Inhibitors of interleukin-1.beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2000 · Expires Dec 14, 2020

    expired

  20. US 6121266

    Pyridazines as interleukin-1.beta. converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 19, 2000 · Expires Sep 14, 2020

    expired

  21. US 6103711

    Inhibitors of interleukin-1.beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Aug 15, 2000 · Expires Aug 10, 2020

    expired

  22. US 6083503

    Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejection

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 4, 2000 · Expires Jun 29, 2020

    expired

  23. US 6063371

    Pharmaceutical compositions comprising a soluble interleukin-4 receptor

    The United States of America as represented by the Secretary of the Army · Granted May 16, 2000 · Expires May 11, 2020

    expired

  24. US 6025147

    Inhibitors of interleukin-1 .beta. converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 15, 2000 · Expires Feb 10, 2020

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.